heparin sodium & dextrose 5% in viaflex liq solution
baxter corporation - heparin sodium; dextrose - solution - 5000unit; 5g - heparin sodium 5000unit; dextrose 5g - heparins
heparin sodium & 5% dextrose injection liq solution
baxter corporation - heparin sodium; dextrose - solution - 10000unit; 5g - heparin sodium 10000unit; dextrose 5g - heparins
heparin sodium 5000unit/500ml in sodium chloride 0.9% solution
hospira healthcare ulc - heparin sodium - solution - 10unit - heparin sodium 10unit - heparins
heparin sodium injection usp (multidose vial-with preservative) solution
sandoz canada incorporated - heparin sodium - solution - 1000unit - heparin sodium 1000unit - heparins
heparin sodium injection usp (single use vial-preservative free) solution
sandoz canada incorporated - heparin sodium - solution - 10000unit - heparin sodium 10000unit - heparins
heparin sodium injection usp (multidose vial-with preservative) solution
sandoz canada incorporated - heparin sodium - solution - 10000unit - heparin sodium 10000unit - heparins
heparin sodium injection
cardinal health - heparin sodium (unii: zz45ab24ca) (heparin - unii:t2410km04a) - heparin 5000 [usp'u] in 1 ml
heparin sodium powder
pharmacia and upjohn company - heparin sodium (unii: zz45ab24ca) (heparin - unii:t2410km04a) - heparin sodium 1 kg in 1 kg
heparin sodium and sodium chloride- heparin sodium injection, solution
baxter healthcare corporation - heparin sodium (unii: zz45ab24ca) (heparin - unii:t2410km04a) - heparin 1000 [iu] in 500 ml
heparin sodium injection, solution
cardinal health 107, llc - heparin sodium (unii: zz45ab24ca) (heparin - unii:t2410km04a) - heparin sodium injection is indicated for: the use of heparin sodium injection is contraindicated in patients with the following conditions: risk summary there are no available data on heparin sodium injection use in pregnant women to inform a drug-associated risk of major birth defects and miscarriage. in published reports, heparin exposure during pregnancy did not show evidence of an increased risk of adverse maternal or fetal outcomes in humans. no teratogenicity, but early embryo-fetal death was observed in animal reproduction studies with administration of heparin sodium to pregnant rats and rabbits during organogenesis at doses approximately 10 times the maximum recommended human dose (mrhd) of 45,000 units/day [see data] . consider the benefits and risks of heparin sodium injection for the mother and possible risks to the fetus when prescribing heparin sodium injection to a pregnant woman. if available, preservative-free heparin sodium injection is recommended when heparin therapy is needed during preg